Nvidia Invests $50M into AI Drug Discovery Fi...

In this episode, we explore the staggering $65 billion raise by Anthropic, propelling them beyond OpenAI’s valuation and transforming the AI landscape. We also discuss innovative moves by companies like Shift and Asana, tackling community-driven robot training and expanding their ...  Show more

In this episode, we explore the critical insights around measuring the return on investment (ROI) of AI technologies in business. Discover why simply implementing AI isn't enough, as we discuss the importance of rethinking productivity, innovation, and the overall impact on how p ...  Show more

Uncover the strategic move by Nvidia as they invest a substantial $50 million in Recursion, a pioneering force in AI-driven drug discovery. Delve into the potential innovations set to revolutionize the intersection of artificial intelligence and pharmaceuticals.

Get ...

Witness a transformative alliance as Nvidia invests a substantial $50 million into Recursion, reshaping the landscape of AI-driven drug discovery. Uncover the potential breakthroughs and revolutionary advancements that could redefine the future of healthcare.

En ...

Dive into the future of pharmaceutical innovation as Nvidia commits a significant $50 million investment into Recursion, a pioneering AI drug discovery firm. Explore the potential breakthroughs and advancements at the intersection of artificial intelligence and life-saving med ...

Explore the transformative potential of Oxolo's €13M funding round, fueling innovation and pushing the boundaries of AI-driven video technology.

Get on the AI Box Waitlist: https://AIBox.ai/ Join our ChatGPT Community: ⁠h ...